Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
November 29, 2017
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
Qian Fan, Xiuting Hu, Haiyang Zhang, et al.
Cancer Cell International
|
July 2, 2024
Blood-based molecular and cellular biomarkers of early response to neoadjuvant PD-1 blockade in patients with non-small cell lung cancer
Xi Zhang, Rui Chen, Zirong Huo, et al.
BMC Cancer
|
October 30, 2024
First-line treatment with gefitinib in combination with bevacizumab and chemotherapy in advanced non-squamous NSCLC with EGFR-mutation
Yanjuan Xiong, Lu Wang, Weihong Zhang, et al.
Plos One
|
September 9, 2014
Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer
Chenguang Li, Ligang Hao, Yue Li, et al.
Frontiers in Pharmacology
|
December 22, 2022
Advances in extraction methods, chemical constituents, pharmacological activities, molecular targets and toxicology of volatile oil from <i>Acorus calamus</i> var. <i>angustatus</i> Besser
Daoming Bai, Xiaoyu Li, Shengguang Wang, et al.
International Journal of Biological Macromolecules
|
July 17, 2022
A review on the advances in the extraction methods and structure elucidation of Poria cocos polysaccharide and its pharmacological activities and drug carrier applications
Tianren Xu, Hongmeng Zhang, Shengguang Wang, et al.
ACS Central Science
|
December 4, 2025
Isopotential Electron Titration: Hydrogen Adsorbate-Metal Charge Transfer
Justin A Hopkins, Benjamin J Page, Shengguang Wang, et al.
Signal Transduction and Targeted Therapy
|
January 16, 2026
Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial
Meng Wang, Weiran Liu, Hongbo Guo, et al.
Oncotarget
|
June 23, 2016
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC
Weiran Liu, Yuesong Yin, Jun Wang, et al.
Nanoscale
|
August 27, 2024
Rational design of nanoscale stabilized oxide catalysts for OER with OC22
Richard Tran, Liqiang Huang, Yuan Zi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
November 29, 2017
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
Qian Fan, Xiuting Hu, Haiyang Zhang, et al.
Cancer Cell International
|
July 2, 2024
Blood-based molecular and cellular biomarkers of early response to neoadjuvant PD-1 blockade in patients with non-small cell lung cancer
Xi Zhang, Rui Chen, Zirong Huo, et al.
BMC Cancer
|
October 30, 2024
First-line treatment with gefitinib in combination with bevacizumab and chemotherapy in advanced non-squamous NSCLC with EGFR-mutation
Yanjuan Xiong, Lu Wang, Weihong Zhang, et al.
Plos One
|
September 9, 2014
Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer
Chenguang Li, Ligang Hao, Yue Li, et al.
Frontiers in Pharmacology
|
December 22, 2022
Advances in extraction methods, chemical constituents, pharmacological activities, molecular targets and toxicology of volatile oil from <i>Acorus calamus</i> var. <i>angustatus</i> Besser
Daoming Bai, Xiaoyu Li, Shengguang Wang, et al.
International Journal of Biological Macromolecules
|
July 17, 2022
A review on the advances in the extraction methods and structure elucidation of Poria cocos polysaccharide and its pharmacological activities and drug carrier applications
Tianren Xu, Hongmeng Zhang, Shengguang Wang, et al.
ACS Central Science
|
December 4, 2025
Isopotential Electron Titration: Hydrogen Adsorbate-Metal Charge Transfer
Justin A Hopkins, Benjamin J Page, Shengguang Wang, et al.
Signal Transduction and Targeted Therapy
|
January 16, 2026
Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial
Meng Wang, Weiran Liu, Hongbo Guo, et al.
Oncotarget
|
June 23, 2016
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC
Weiran Liu, Yuesong Yin, Jun Wang, et al.
Nanoscale
|
August 27, 2024
Rational design of nanoscale stabilized oxide catalysts for OER with OC22
Richard Tran, Liqiang Huang, Yuan Zi, et al.
Page
of 4